John S. Bradley spends much of his time researching Internal medicine, Surgery, Intensive care medicine, Streptococcus pneumoniae and Meningitis. His studies deal with areas such as Bacteremia, Placebo and Gastroenterology as well as Internal medicine. His Intensive care medicine study combines topics from a wide range of disciplines, such as MEDLINE and Pulmonology.
His research investigates the connection between Streptococcus pneumoniae and topics such as Ceftriaxone that intersect with problems in Vancomycin. His Meningitis research includes themes of Randomization, Antibacterial agent and Immunology. His Alternative medicine research is multidisciplinary, incorporating perspectives in Drug development, Human services, Medical research and Call to action.
John S. Bradley mainly investigates Internal medicine, Intensive care medicine, Pediatrics, Antibiotics and Surgery. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Streptococcus pneumoniae. In his study, which falls under the umbrella issue of Streptococcus pneumoniae, Immunology is strongly linked to Meningitis.
His Intensive care medicine research includes elements of Vancomycin, Antimicrobial, MEDLINE and Clinical trial. His work on Antibiotics deals in particular with Antibacterial agent and Antibiotic resistance. As part of one scientific family, John S. Bradley deals mainly with the area of Pharmacokinetics, narrowing it down to issues related to the Dosing, and often Pharmacodynamics.
His primary scientific interests are in Internal medicine, Malaria, Intensive care medicine, Dosing and Plasmodium falciparum. John S. Bradley has researched Malaria in several fields, including Tropical medicine, Resistance and Environmental health. In his work, Cohort study is strongly intertwined with Odds ratio, which is a subfield of Environmental health.
His work is dedicated to discovering how Intensive care medicine, Vancomycin are connected with Methicillin-resistant Staphylococcus aureus and other disciplines. His Dosing research incorporates elements of Tobramycin, Aminoglycoside and Pharmacodynamics. His Gametocyte, Artemether/lumefantrine and Artemisinin study in the realm of Plasmodium falciparum connects with subjects such as Primaquine.
Malaria, Internal medicine, Intensive care medicine, Dosing and Vancomycin are his primary areas of study. His study in Malaria is interdisciplinary in nature, drawing from both Tropical medicine, Socioeconomics and Environmental health. In his works, he undertakes multidisciplinary study on Environmental health and Context.
His Internal medicine study which covers Antibiotics that intersects with Bacteria, Gram and Precision medicine. The concepts of his Intensive care medicine study are interwoven with issues in Infectious disease, Ambulatory care, MEDLINE, Treatment outcome and Virus. In his study, Meningitis and Randomization is inextricably linked to Pharmacotherapy, which falls within the broad field of Vancomycin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher;George H. Talbot;John S. Bradley;John S. Bradley;John E. Edwards;John E. Edwards.
Clinical Infectious Diseases (2009)
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
Brad Spellberg;Robert Guidos;David Gilbert;John Bradley;John Bradley.
Clinical Infectious Diseases (2008)
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
Joseph S. Solomkin;John E. Mazuski;John S. Bradley;Keith A. Rodvold.
Clinical Infectious Diseases (2010)
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
George H. Talbot;John Bradley;John Bradley;John E. Edwards;David Gilbert.
Clinical Infectious Diseases (2006)
The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
John S. Bradley;Carrie L. Byington;Samir S. Shah;Brian Alverson.
Clinical Infectious Diseases (2011)
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.
Kazuaki Nishijima;Yin-Shan Ng;Lichun Zhong;John Bradley.
American Journal of Pathology (2007)
Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
Scott A. Harper;John S. Bradley;Janet A. Englund;Thomas M. File.
Clinical Infectious Diseases (2009)
10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
Helen W. Boucher;George H. Talbot;Daniel K. Benjamin;Daniel K. Benjamin;John Bradley;John Bradley.
Clinical Infectious Diseases (2013)
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R Burmester;Ricardo Blanco;Christina Charles-Schoeman;Jürgen Wollenhaupt.
The Lancet (2013)
Combating antimicrobial resistance: policy recommendations to save lives.
Spellberg B;Blaser M;Guidos Rj.
Clinical Infectious Diseases (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Baylor College of Medicine
Radboud University Nijmegen
Baylor College of Medicine
University of Alabama at Birmingham
University of London
University of Wisconsin–Madison
University of Pittsburgh
University of London
Cincinnati Children's Hospital Medical Center
Northwestern University
University of Melbourne
Technical University of Denmark
Queen's University
University of Science and Technology Beijing
Institució Catalana de Recerca i Estudis Avançats
University of Southampton
University of Utah
Tokyo University of Pharmacy and Life Sciences
International Center for Agricultural Research in the Dry Areas, Morocco
University of Utah
Goddard Institute for Space Studies
Yale University
Fujita Health University
University of Washington
National and Kapodistrian University of Athens
TU Dresden